Date of first VCS test:  Tue Jan 7 12:44:06 2014 (EST)
Date of most recent VCS test:  Thu Apr 19 11:42:47 2018 (EDT)
Time site in operation:  1562.9 days

Tests with POSITIVE results (suggesting neurotoxin exposure is likely):  74.3%
Tests with NEGATIVE results (suggesting neurotoxin exposure is unlikely):  25.7%


Percentage of VCS test takers responding to at least 1 survey question:  77.4%

Percentage of VCS test takers self-rating their overall health on a scale of 1-10 (10 being highest/best):  76.7%
   Average self-rated overall health among all respondents:  5.77
   Average self-rated overall health among respondents with POSITIVE test results:  5.67
   Average self-rated overall health among respondents with NEGATIVE test results:  6.03

Percentage of VCS test takers who responded regarding recent mold exposure or suspected mold exposure:  76%
   Percentage reporting recent mold exposure or suspected mold exposure:  59.5%
      With POSITIVE test results:  75.7%
      With NEGATIVE test results:  24.3%
   Percentage reporting NO recent mold exposure or suspected mold exposure:  40.5%
      With POSITIVE test results:  71.8%
      With NEGATIVE test results:  28.2%

Percentage of VCS test takers who responded regarding mold illness diagnosis:  45.3%
   Percentage reporting mold illness diagnosis:  20.5%
      With POSITIVE test results:  74.8%
      With NEGATIVE test results:  25.2%
   Percentage reporting NO mold illness diagnosis:  79.5%
      With POSITIVE test results:  75.8%
      With NEGATIVE test results:  24.2%

Percentage of VCS test takers who responded regarding exposures to other neurotoxins:  75.3%
   Percentage reporting exposure to other neurotoxins:  37%
      With POSITIVE test results:  75%
      With NEGATIVE test results:  25%
   Percentage reporting NO exposure to other neurotoxins:  63%
      With POSITIVE test results:  73.5%
      With NEGATIVE test results:  26.5%

Percentage of VCS test takers who responded regarding diagnosis with exposure to other neurotoxins:  28.1%
   Percentage reporting diagnosis with exposure to other neurotoxins:  29.9%
      With POSITIVE test results:  73.8%
      With NEGATIVE test results:  26.2%
   Percentage reporting NO diagnosis with exposure to other neurotoxins:  70.1%
      With POSITIVE test results:  75%
      With NEGATIVE test results:  25%

Percentage of VCS test takers who responded regarding other conditions involving neurological function:  75.3%
   Percentage reporting suffering from a condition involving neurological function:  28.4%
      With POSITIVE test results:  74.8%
      With NEGATIVE test results:  25.2%
   Percentage reporting suffering from NO condition involving neurological function:  71.6%
      With POSITIVE test results:  73.8%
      With NEGATIVE test results:  26.2%